Drug Type Small molecule drug |
Synonyms MAI-001, MAI001, MI 078 + [2] |
Target |
Action modulators |
Mechanism GABAA receptor modulators(Gamma-aminobutyric acid A receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depression, Postpartum | Phase 3 | China | 09 Jul 2026 | |
| Depressive Disorder | Phase 3 | United States | - |
CTR20242132 (NEWS) Manual | Phase 2 | - | fhhbtjantk(rhltadpjdm) = lvqrvuwull hffenknqhl (yyrgsjjhkr ) | Positive | 20 Aug 2025 | ||
- |





